Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/268383
Year of Publication: 
2023
Series/Report no.: 
ARTNeT Working Paper Series No. 225
Publisher: 
Asia-Pacific Research and Training Network on Trade (ARTNeT), Bangkok
Abstract: 
Timely and equitable access to vaccines and other health technologies is vital in effectively responding to pandemics and treating other communicable diseases. This paper shows how countries might overcome real or purported intellectual property (IP) barriers to regional COVID-19 vaccine production. In particular, it examines how countries can utilise IP flexibilities to increase and diversify the manufacture and distribution of COVID-19 vaccines. It provides concrete examples of how these flexibilities are practised in various domestic jurisdictions in Asia and the Pacific and sets out practical recommendations for different policy areas.
Subjects: 
COVID-19
vaccines
intellectual property rights
regional cooperation
Asia-Pacific
JEL: 
F13
O34
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.